/Companies

Galen Health

Techstars '25

Pittsburgh, US · 13 employees on LinkedIn · 1 known investors

Find your way into Galen Health

Sign up to see every warm intro you have to Galen Health

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Galen Health team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Galen builds causal, computational models of living cells ("virtual cells") that aim to predict how a cell changes under a given intervention before experiments are run. Its initial focus is durability and exhaustion in engineered T cell therapies, serving scientists and drug developers working on cell therapies.

Also known as Galen

Founders & leadership

LNLogan Nye
Logan NyeCo-founder & CEOLogan Nye is co-founder and CEO of Galen Health, which develops computational models of living cells to predict cellular responses to interventions for drug development and cell therapy research.
KAKushagra Agarwal
Kushagra AgarwalCo-founder & CTO

Investors · 1

Techstarslisted by TechstarsBoulder · $220K

How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us

Company profile

researched Sep 2026

Galen describes itself as a virtual cell company building causal models of living cells that state what will change under a given intervention before the next experiment begins. The company frames the gap in current biology as one between high-resolution measurement of cellular state and models that describe what cells look like rather than what they do when something is altered; it positions causal modeling, rather than correlation, as the way to determine which intervention moves a biological system and by how much.

The company's stated initial problem area is durability and exhaustion in engineered T cell therapies — cells that work and then stop working — chosen because the outcome depends on upstream biological choices that descriptive models cannot resolve. Galen's stated mission is to solve disease from first principles, and it emphasizes that a virtual cell model must remain answerable to experiment.

A separate Techstars job board listing for galenhealth.org (Pittsburgh, PA and Windsor, OH; health care; 11-50 employees; founded 2024) describes a two-step pancreatic cancer early detection approach in which AI scans routine electronic health records to identify high-risk patients, who then receive liquid biopsies twice a year to monitor for early signs of cancer.

▸Full profile — market position, technology, go-to-market, geography

Market position

Positions itself as a virtual cell company operating between high-resolution biological measurement and laboratory experimentation, focused on causal prediction rather than descriptive modeling of cellular state.

Technology

Galen's approach centers on causal, computational models of cells that make predictions about the effect of an intervention ahead of laboratory work. The company describes an iterative loop of predict, measure, learn and design: state what will change before an experiment, let physical biology adjudicate what the model got right, use each result to refine the next question, and translate measured understanding into deliberate biological design. The stated aims are to reduce blind search by comparing candidate changes computationally before committing lab time, budget and cells, and to make model uncertainty explicit so the next measurement can reduce it.

Go-to-market

The company's site invites direct contact from prospective collaborators, partners and funders rather than describing a productized sales motion.

Scientists, engineers, partners, funders and company builders working on virtual cells, programmable biology, scientific software and the interface of computation and living systems; the initial biological focus is engineered cell therapy development.

Geography

Listed locations are Pittsburgh, Pennsylvania and Windsor, Ohio, United States.

Compiled by commissioned research from 6 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Employee count rangeJan 202411-50
Founded yearJan 20242,024 year

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Related companies · 1

Companies working in the same space as Galen Health.

▸Research sources · 6

primary sources listed

6 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Galen Health do?
Galen builds causal computational models of living cells to predict how cells respond to interventions before experiments are run.
Who founded Galen Health?
Galen Health was founded by Logan Nye, Kushagra Agarwal.
Who are Galen Health's investors?
Galen Health's investors include Techstars.
Where is Galen Health headquartered?
Galen Health is headquartered in Pittsburgh, US.